Purchase Order 75F40122P00457
Award Date
9/8/22
Potential Completion Date
9/29/23
Potential Value
$41K
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
B529 - Special Studies/Analysis- Scientific Data
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
La Jolla, CA 92037, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award for $1,049,692.00 was issued by the Centers for Disease Control and Prevention (CDC) to the La Jolla Institute for Immunology, a non-profit research institute. The contract, which does not have a set-aside designation, supports a "Systemic Assessment of Immunity to B. Pertussis Using Validated Assays & Data Integration" under Broad Agency Announcement (BAA) Topic 22.3. The contract is a definitive contract with a cost-no-fee pricing type and an...
This is a firm fixed-price purchase order contract awarded by the Department of the Navy Bureau of Medicine and Surgery to the La Jolla Institute for Immunology (LJI), a non-profit research institute. The contract, with a potential value of $431,181.80, is for "RESEARCH - IMMUNOLOGIC CELL RESPONSES" and has an anticipated completion date of April 30, 2022. LJI has previously supported federal agencies such as the CDC, FDA, VA, and Navy through prime and subcontract research on topics...
This is a $36,549,202.01 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the La Jolla Institute for Immunology, a non-profit research institute, for the Immune Epitope and Analysis Program. The contract has no set-aside designation and is set to run until December 14, 2025. As the prime contractor, the La Jolla Institute for Immunology is responsible for the overall program, which involves conducting research and providing services related to...
This firm fixed-price purchase order contract, valued at $75,848.00, was awarded by the Bureau of Medicine and Surgery, a defense agency, to the La Jolla Institute for Immunology, a non-profit research institute. The contract has two main tasks: 1) Predicting MHC class I and II epitopes for 400 prioritized Plasmodium falciparum proteins based on HLA data from 28 research subjects, and 2) Predicting MHC class I and II epitopes within the three NAVOX vaccine antigens (CSP, AMA1, and TRAP) based on...
This is a $4,495,633 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the La Jolla Institute for Immunology, a non-profit research institute, for "LARGE SCALE T CELL EPITOPE DISCOVERY". The contract has no set-aside designation. The contract involves T cell and B cell immunology research, including epitope identification, vaccine development, and studies on the immune mechanisms underlying infectious diseases, allergies, autoimmune...
This is a federal contract award (HHSN272200900044C) to the La Jolla Institute for Immunology, a non-profit research institute, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is for biomedical research services, has a ceiling value of $6,282,425.17, and was awarded on September 30, 2009 with a final completion date of September 29, 2014. The contract is a definitive contract with a cost-no-fee pricing...
This is a federal contract award (HHSN272200700048C) from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the La Jolla Institute for Immunology, a non-profit research institute. The $6,415,863 definitive contract is for biomedical research services, with a period of performance from September 2007 to December 2014. The contract does not have a set-aside designation. The La Jolla Institute for Immunology specializes in...
This is a definitive federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the La Jolla Institute for Immunology, a non-profit research institute. The contract, valued at $5,624,672.00, is for the identification and characterization of T cell epitopes from bacterial pathogens causing pneumonia. This research aims to advance the understanding of immune responses to these bacterial...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $5,624,889.00 definitive contract to the La Jolla Institute For Immunology, a non-profit research institute. The contract is for the identification and validation of epitopes conserved in viral pathogen families with pandemic potential. This is a cost-no-fee contract with a period of performance through September 29, 2025. The contract has no set-aside designation. The La Jolla Institute For...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the La Jolla Institute for Immunology (LJII), a non-profit research institute. The contract, valued at $52,963,056.00, is for the "IMMUNE EPITOPE DATABASE AND ANALYSIS PROGRAM" and does not have a set-aside designation. The contract is a definitive contract with a cost-no-fee pricing type, with a period of performance ending on...